December 22, 2016
3 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: "Modest associations" found between baseline factors, steroid use
WASHINGTON — At the American College of Rheumatology Annual Meeting, Matthew D. Cascino, MD, in the Division of Rheumatology at the University of California, San Francisco, reviewed his study on several factors — relapsing disease, BMI, PR3 positivity and induction treatment with rituximab — and their association with glucocorticoid exposure in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Cascino and colleagues found relapsing disease, as well as increased BMI, were associated with increased glucocorticoid exposure. In addition, PR3 positivity was associated with decreased exposure. Overall, Cascino said there was a “modest association” between these factors and steroid use.